Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

News briefs

House report questions FDA’s approval of Alzheimer’s drug

Tribune News Service

Congress Targets FDA, Biogen on Alzheimer's Drug Approval

A congressional report finds the FDA's approval process for Biogen's Alzheimer's treatment was 'rife with irregularities' that included 'atypical collaboration.'

The Street

Probe: Alzheimer's drug approval 'rife with irregularities'

The Food and Drug Administration's contentious approval of a questionable Alzheimer's drug is taking another hit

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

House report questions FDA’s approval of Alzheimer’s drug

WASHINGTON — A joint investigation released Thursday by House Democrats identified unusual collaboration between Food and Drug Administration officials and drugmaker Biogen, highlighting potential problems in the agency’s approval of the controversial Alzheimer’s drug Aduhelm.

Tribune News Service

US congressional report slams FDA approval of Alzheimer's drug

Washington (AFP) - The US Food and Drug Administration's approval process for a controversial drug used to treat Alzheimer's was "rife with irregularities," a congressional report said Thursday.

AFP

Evie’s smart ring is ‘designed for women’ and aimed at challenging Oura

The Evie smart ring targets women's health and is aiming to be FDA-approved. Movano says it will ideally cost less than $300 when it launches sometime in 2023.

Inverse

3 Stocks to Help You Get Through Today's Market Fear

Instead of a Santa Claus rally, the market continues to experience volatility at the end of the year with uncertainties surrounding the reopening of the Chinese economy and a looming recession due to seemingly unending interest rate hikes. Given this backdrop, loading up on fundamentally strong stocks Walmart (WMT), Pfizer…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

House report questions FDA's approval of Alzheimer's drug - Roll Call

House Democrats releases a report highlighting potential problems in the FDA's approval of Alzheimer's drug Aduhelm.

Roll Call

A simple device could prevent thousands of maternal deaths. Why did it take so long to get to market?

Alydia Health's Jada system for postpartum hemorrhage took 11 years to reach the market; being a women's health product made its road tougher.

Fortune

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

StockNews.com

Blood-Pressure Medication Recalled Due to Impurity

This is the second time a company has recalled blood-pressure medication in recent months.

The Street

Making pig livers humanlike in quest to ease organ shortage

Scientists are transforming pig livers to look and act like human ones, part of a quest to ease the nation's organ shortage

The Independent UK

FDA changes Plan B label to clarify 'morning-after' pill doesn't cause abortion

The agency in a memo Friday said the emergency contraception pills are not the same as abortion pills — which end a pregnancy — a fact that has long been understood in the medical community.

WEKU

FDA changes Plan B label, clarifies it won't cause abortion

The Food and Drug Administration announced Friday that it will overhaul packaging labels for the emergency contraceptive pill, Plan B, that women can take after having sex to prevent a pregnancy

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Investors Business Daily

Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023?

Crispr expects to make history in 2023 with a first-ever request in gene-editing technology by the same name, which could stoke shares.

The Independent UK

New label law has unintended effect: Sesame in more foods

A new federal law requiring that sesame be listed as an allergen on food labels is having unintended consequences _ increasing the number of products that include the ingredient

Axios

Congress saves big health care decisions for last

The health care riders in the year-end spending package that emerged on Monday reflect which health care interests have clout, and which issues lawmakers want to punt into next year.

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

States challenge Biden to lower drug prices by allowing imports from Canada

The Biden administration is facing mounting pressure from states to let them import medicine from Canada to help lower prescription drug costs.

The Independent UK

Panel warns FDA’s beleaguered tobacco unit lacks direction

A new report criticizes the Food and Drug Administration’s efforts to oversee the tobacco industry, including traditional cigarettes and vaping products

Tribune News Service

Medtronic sees 23 serious medical device recalls in two years

Medtronic, battered by a high number of serious medical device recalls in recent years, says it is toughening its internal assessments for acquiring new products.

Reason

Big Dairy Wants Congress To Restore Huge Tariffs on Imported Baby Formula

Unless Congress takes action, those tariffs will return on January 1. And the baby formula shortage hasn't yet passed.

Daily Mirror

Humans' Diet Coke addiction linked to rising anxiety due to artificial sweetener

Scientists tested the artificial sweetener - which is found in most diet fizzy drinks - on mice, finding it induced anxiety and even produced changes in their brains

Inverse

Prescription poop could be the future of medicine

Last month, the FDA approved a fecal-based treatment for the first time. This approval is likely only the start of a promising future for prescription poop.

Tribune News Service

Sen. Schumer calls on FDA for action on kids’ medicine shortages amid surge of COVID, RSV and flu

The FDA needs to take action as New York City and Long Island suffer from dangerous “spot shortages” of medicine for children due to the triple threat of COVID, RSV and the flu, Sen. Chuck Schumer said Sunday.

1 … 105 106 107 108

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.